-on-period basis was attributable to the Company having some costs in personnel, doctor fee, drugs and medical supplies, depreciation, electricity charge, medical utensils costs, and medical consumable
-products from sugar production process including molasses and electricity. Top 10 Major Shareholders(@11 Mar 2022) Share % 1. บริษัท ครบุรี แคปิตอล จำกัด 165,307,800 27.55 2. MITSUI & CO.,LTD. 66,666,666
, or 23% of the total mobile base. Profit growth continued in tandem with business expansion 2Q24 EBITDA was Bt27,621mn, increasing 19%YoY accelerated from TTTBB positive EBITDA contribution and core
, or 23% of the total mobile base. Profit growth continued in tandem with business expansion 2Q24 EBITDA was Bt27,621mn, increasing 19%YoY accelerated from TTTBB positive EBITDA contribution and core
DCON PRODUCTS PUBLIC Co.,Ltd. and Subsidiaries Company Management’s Discussion and Analysis (MD&A) For the Year 2017 1. Revenue,Gross Profit & Net Profit Unit :M.Bht Year 2017 Year 2016 Year 2015 1
DCON PRODUCTS PUBLIC Co.,Ltd. and Subsidiaries Company Management’s Discussion and Analysis (MD&A) For the Year 2018 1. Revenue,Gross Profit & Net Profit Unit :M.Bht Year 2018 Year 2017 Year 2016 1
incomes 2.87 0.65% 2.90 0.74% 0.03 0.89% Revenue from rental incomes 2.44 0.55% 2.63 0.67% 0.19 7.26% Total revenues 444.32 100.00% 393.34 100.00% (50.98) -12.96% Gross Profit / Margin 121.70 27.39% 99.52
% Gross Profit / Margin 99.46 28.54% 79.70 25.83% Net Profit / Margin 20.17 5.79% 6.28 2.04% Revenue from sales and services The Company’s sales and services revenue is reduced by THB 39.93 million or
2.87 0.65% 2.90 0.74% 0.03 0.89% Revenue from rental incomes 2.44 0.55% 2.63 0.67% 0.19 7.26% Total revenues 393.34 100.00% 444.32 100.00% (50.98) -12.96% Gross Profit / Margin 121.70 27.39% 99.52 25.30
Income as of third quarter of 2019 per following table: (THB) Million 3Q19 3Q18 9M19 9M18 Total Revenues 130.55 124.06 392.30 392.98 Total Expenses (120.99) (120.70) (372.77) (365.21) Shares of Profit